Search

Janet L. Coppins

Examiner (ID: 9929, Phone: (571)272-0680 , Office: P/1672 )

Most Active Art Unit
1628
Art Unit(s)
1621, 1672, 1628, 1625, 1626
Total Applications
1605
Issued Applications
1046
Pending Applications
231
Abandoned Applications
369

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18737876 [patent_doc_number] => 20230346776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => VETERINARY COMPOSITION FOR DAIRY RUMINANTS FOR TREATMENT OF MILK FEVER [patent_app_type] => utility [patent_app_number] => 17/793328 [patent_app_country] => US [patent_app_date] => 2021-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3587 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793328 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/793328
VETERINARY COMPOSITION FOR DAIRY RUMINANTS FOR TREATMENT OF MILK FEVER Jan 25, 2021 Pending
Array ( [id] => 19825260 [patent_doc_number] => 12246014 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-11 [patent_title] => Azetidine derivatives [patent_app_type] => utility [patent_app_number] => 17/148785 [patent_app_country] => US [patent_app_date] => 2021-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13899 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148785 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/148785
Azetidine derivatives Jan 13, 2021 Issued
Array ( [id] => 18150526 [patent_doc_number] => 20230024384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => COMPOSITION COMPRISING LISURIDE COMPOUND FOR TREATING FRAGILE X SYNDROME OR RELATED DEVELOPMENTAL DISORDERS [patent_app_type] => utility [patent_app_number] => 17/790891 [patent_app_country] => US [patent_app_date] => 2021-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5660 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790891 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/790891
COMPOSITION COMPRISING LISURIDE COMPOUND FOR TREATING FRAGILE X SYNDROME OR RELATED DEVELOPMENTAL DISORDERS Jan 7, 2021 Pending
Array ( [id] => 18166621 [patent_doc_number] => 20230033224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => CICLESONIDE FOR AMELIORATING QUALITY OF LIFE (QOL) IN EQUINES [patent_app_type] => utility [patent_app_number] => 17/758427 [patent_app_country] => US [patent_app_date] => 2021-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4357 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758427 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/758427
CICLESONIDE FOR AMELIORATING QUALITY OF LIFE (QOL) IN EQUINES Jan 5, 2021 Pending
Array ( [id] => 19666093 [patent_doc_number] => 12178813 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-31 [patent_title] => CGRP receptor antagonists [patent_app_type] => utility [patent_app_number] => 17/139299 [patent_app_country] => US [patent_app_date] => 2020-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12382 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17139299 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/139299
CGRP receptor antagonists Dec 30, 2020 Issued
Array ( [id] => 18946998 [patent_doc_number] => 11890270 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-06 [patent_title] => Polymorphic forms of ST-246 and methods of preparation [patent_app_type] => utility [patent_app_number] => 17/136674 [patent_app_country] => US [patent_app_date] => 2020-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 16966 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17136674 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/136674
Polymorphic forms of ST-246 and methods of preparation Dec 28, 2020 Issued
Array ( [id] => 19097735 [patent_doc_number] => 20240116963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => DENDRIMERS HAVING THIOPHOSPHORAMIDATE PATTERNS AND DERIVATIVES [patent_app_type] => utility [patent_app_number] => 17/788114 [patent_app_country] => US [patent_app_date] => 2020-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25680 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788114 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/788114
DENDRIMERS HAVING THIOPHOSPHORAMIDATE PATTERNS AND DERIVATIVES Dec 21, 2020 Pending
Array ( [id] => 18182474 [patent_doc_number] => 20230043204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => DIHYDROERGOTAMINE MESYLATE FORMULATIONS AND PRE-FILLED INJECTORS FOR THERAPEUTIC DELIVERY OF THE SAME [patent_app_type] => utility [patent_app_number] => 17/757924 [patent_app_country] => US [patent_app_date] => 2020-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20565 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -112 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17757924 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/757924
DIHYDROERGOTAMINE MESYLATE FORMULATIONS AND PRE-FILLED INJECTORS FOR THERAPEUTIC DELIVERY OF THE SAME Dec 20, 2020 Pending
Array ( [id] => 18182474 [patent_doc_number] => 20230043204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => DIHYDROERGOTAMINE MESYLATE FORMULATIONS AND PRE-FILLED INJECTORS FOR THERAPEUTIC DELIVERY OF THE SAME [patent_app_type] => utility [patent_app_number] => 17/757924 [patent_app_country] => US [patent_app_date] => 2020-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20565 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -112 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17757924 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/757924
DIHYDROERGOTAMINE MESYLATE FORMULATIONS AND PRE-FILLED INJECTORS FOR THERAPEUTIC DELIVERY OF THE SAME Dec 20, 2020 Pending
Array ( [id] => 16913891 [patent_doc_number] => 20210186983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => ORALLY ADMINISTERED COMBINATIONS OF AMOXICILLIN AND AVIBACTAM DERIVATIVES FOR TREATING MYCOBACTERIAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/123858 [patent_app_country] => US [patent_app_date] => 2020-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22067 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -57 [patent_words_short_claim] => 275 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17123858 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/123858
ORALLY ADMINISTERED COMBINATIONS OF AMOXICILLIN AND AVIBACTAM DERIVATIVES FOR TREATING MYCOBACTERIAL INFECTIONS Dec 15, 2020 Abandoned
Array ( [id] => 17168671 [patent_doc_number] => 20210322341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => LOW DOSAGE SEROTONIN 5-HT2A RECEPTOR AGONIST TO SUPPRESS INFLAMMATION [patent_app_type] => utility [patent_app_number] => 17/108153 [patent_app_country] => US [patent_app_date] => 2020-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9238 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17108153 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/108153
LOW DOSAGE SEROTONIN 5-HT2A RECEPTOR AGONIST TO SUPPRESS INFLAMMATION Nov 30, 2020 Abandoned
Array ( [id] => 16898863 [patent_doc_number] => 20210177779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => COMBINATIONS OF OPIOIDS AND N-ACYLETHANOLAMINES [patent_app_type] => utility [patent_app_number] => 17/105687 [patent_app_country] => US [patent_app_date] => 2020-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11393 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17105687 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/105687
COMBINATIONS OF OPIOIDS AND N-ACYLETHANOLAMINES Nov 26, 2020 Pending
Array ( [id] => 16686696 [patent_doc_number] => 20210069171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => NUTRITIONAL SUPPLEMENT FOR IMPROVING SEXUAL HEALTH IN MEN AND WOMEN [patent_app_type] => utility [patent_app_number] => 16/953110 [patent_app_country] => US [patent_app_date] => 2020-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1229 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16953110 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/953110
NUTRITIONAL SUPPLEMENT FOR IMPROVING SEXUAL HEALTH IN MEN AND WOMEN Nov 18, 2020 Abandoned
Array ( [id] => 16805954 [patent_doc_number] => 20210128507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => FORMULATION FOR USE IN A METHOD OF TREATMENT OF PAIN [patent_app_type] => utility [patent_app_number] => 17/098923 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6550 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098923 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098923
FORMULATION FOR USE IN A METHOD OF TREATMENT OF PAIN Nov 15, 2020 Abandoned
Array ( [id] => 16655978 [patent_doc_number] => 20210052614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => BORON-CONTAINING SMALL MOLECULES FOR INHIBITING ACTIVITY OF A RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASE [patent_app_type] => utility [patent_app_number] => 17/087962 [patent_app_country] => US [patent_app_date] => 2020-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10020 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17087962 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/087962
BORON-CONTAINING SMALL MOLECULES FOR INHIBITING ACTIVITY OF A RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASE Nov 2, 2020 Abandoned
Array ( [id] => 16791620 [patent_doc_number] => 20210121437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => THERAPEUTIC AGENTS CONTAINING CANNABIS FLAVONOID DERIVATIVES TARGETING KINASES, SIRTUINS AND ONCOGENIC AGENTS FOR THE TREATMENT OF MULTIPLE MYELOMA, LYMPHOMA, AND LEUKEMIA [patent_app_type] => utility [patent_app_number] => 17/083716 [patent_app_country] => US [patent_app_date] => 2020-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6049 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083716 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/083716
THERAPEUTIC AGENTS CONTAINING CANNABIS FLAVONOID DERIVATIVES TARGETING KINASES, SIRTUINS AND ONCOGENIC AGENTS FOR THE TREATMENT OF MULTIPLE MYELOMA, LYMPHOMA, AND LEUKEMIA Oct 28, 2020 Abandoned
Array ( [id] => 16655880 [patent_doc_number] => 20210052516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => METHOD FOR INCREASING AKKERMANSIA IN INTESTINAL BACTERIAL FLORA BY INGESTING ASTAXANTHIN [patent_app_type] => utility [patent_app_number] => 17/080118 [patent_app_country] => US [patent_app_date] => 2020-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3742 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17080118 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/080118
METHOD FOR INCREASING AKKERMANSIA IN INTESTINAL BACTERIAL FLORA BY INGESTING ASTAXANTHIN Oct 25, 2020 Abandoned
Array ( [id] => 16961462 [patent_doc_number] => 20210212961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => CANNABINOID-CONTAINING COMPLEX MIXTURES FOR THE TREATMENT OF MAST CELL-ASSOCIATED OR BASOPHIL-MEDIATED INFLAMMATORY DISORDERS [patent_app_type] => utility [patent_app_number] => 17/065400 [patent_app_country] => US [patent_app_date] => 2020-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15214 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17065400 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/065400
CANNABINOID-CONTAINING COMPLEX MIXTURES FOR THE TREATMENT OF MAST CELL-ASSOCIATED OR BASOPHIL-MEDIATED INFLAMMATORY DISORDERS Oct 6, 2020 Abandoned
Array ( [id] => 16748757 [patent_doc_number] => 20210100766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-08 [patent_title] => METHODS OF SUSTAINING DIETARY KETOSIS AND ITS EFFECTS ON LIPID PROFILE [patent_app_type] => utility [patent_app_number] => 17/063183 [patent_app_country] => US [patent_app_date] => 2020-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7437 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063183 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/063183
METHODS OF SUSTAINING DIETARY KETOSIS AND ITS EFFECTS ON LIPID PROFILE Oct 4, 2020 Abandoned
Array ( [id] => 16596464 [patent_doc_number] => 20210022995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => INTRANASAL DELIVERY OF DIHYDROERGOTAMINE BY PRECISION OLFACTORY DEVICE [patent_app_type] => utility [patent_app_number] => 17/062364 [patent_app_country] => US [patent_app_date] => 2020-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13551 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17062364 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/062364
Intranasal delivery of dihydroergotamine by precision olfactory device Oct 1, 2020 Issued
Menu